Clinical trial

Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage…

NCT00005065 · National Cancer Institute (NCI), NIH · Completed

Key facts

NCT number NCT00005065
Title Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer
Official title A Phase I Study of Induction Carboplatin / Paclitaxel Chemotherapy, Pre-operative Radiotherapy With Gadolinium Texaphyrin (Gd-Tex), and Surgical Resection in Stage IIIA (N2) Non-small Cell Lung Carcinoma.
Lead sponsor National Cancer Institute (NCI), NIH
Status Completed
Phase Phase 1
Study type Interventional
Conditions Stage IIIA Non-small Cell Lung Cancer
Intervention type Drug, Procedure, Radiation
Interventions paclitaxel, carboplatin, motexafin gadolinium, conventional surgery, radiation therapy
Enrollment 12
Start date Jan 1, 2000
Primary completion Dec 1, 2003
First posted May 7, 2003
Last update posted Jun 4, 2013
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies